Avai Bio (AVAI) Operating Expenses (2018 - 2026)

Avai Bio has disclosed Operating Expenses across 9 years of filings, most recently posting $419783.0 for Q2 2026.

• In Q2 2026, Operating Expenses fell 13.91% year-over-year to $419783.0; the TTM figure through Jun 2026 stood at $1.4 million (down 5.91% YoY), while the FY2026 annual figure was $1.5 million, down 3.43% from the prior year.
• Operating Expenses came in at $419783.0 for Q2 2026 at Avai Bio, up from $88162.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.0 million in Q4 2023 to a low of -$38446.0 in Q1 2025.
• Average Operating Expenses over 5 years is $329895.2, with a median of $391497.0 recorded in 2023.
• Year-over-year, Operating Expenses soared 1939.34% in 2023 and tumbled 112.67% in 2025.
• Over 5 years, Operating Expenses stood at $49717.0 in 2022, then soared by 1939.34% to $1.0 million in 2023, then tumbled by 57.7% to $428898.0 in 2024, then advanced by 18.86% to $509774.0 in 2025, then retreated by 17.65% to $419783.0 in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $419783.0 in Q2 2026, $88162.0 in Q1 2026, and $509774.0 in Q4 2025.